Melvexian launched “a new path” for blood thinners by targeting a new pathway. It offered hope for doctors that we could solve a puzzle that had remained a conundrum for too long. So we created direct mail and digital that played to doctors’ problem-solving instinct with a series of visual puzzles of our own.
